Related Experiment Video
Updated: Jul 5, 2026

13:12
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
In the mind's eye: provider and patient attitudes on functional brain imaging.
J Illes1, S Lombera, J Rosenberg
1Stanford Center for Biomedical Ethics, Stanford University, Department of Pediatric, Stanford, CA 94305, United States. jilles@interchange.ubc.ca
Journal of Psychiatric Research
|April 22, 2008
Summary
Brain imaging in major depression shows promise for personalized treatment and reducing stigma. Patients and providers are receptive to using neuroimaging for better understanding and coping with the disorder.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Ethics
Background:
- Functional neuroimaging offers quantitative data for central nervous system disorders, moving beyond qualitative clinical criteria.
- The translation of neuroimaging research to clinical practice, particularly for major depression, is rapidly advancing.
- Clinical neuroethics addresses ethical challenges in transferring neuroimaging research to patient care.
Purpose of the Study:
- To explore the perspectives of mental health providers and patients with major depressive disorder on the integration of clinical neuroimaging.
- To assess the potential impact of neuroimaging on treatment, patient understanding, and societal perceptions of depression.
Main Methods:
- A survey was conducted among mental health providers and patients diagnosed with major depressive disorder.
- Data were collected from 52 providers and 72 patients regarding their views on neuroimaging in depression.
Main Results:
- High receptivity was found among both providers and patients towards using brain scans.
- Participants showed openness to neuroimaging for treatment tailoring, enhancing disease comprehension, and coping mechanisms.
- Neuroimaging was seen as a tool to mitigate stigma and self-blame associated with depression.
Conclusions:
- Validated neuroimaging technology has significant potential to reduce the social burden of highly stigmatized illnesses like depression.
- Proactive ethical considerations are crucial for the responsible implementation of neuroimaging in mental healthcare.
- The findings support the future integration of neuroimaging to benefit patients, families, and healthcare providers.
Related Concept Videos
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

